Published in Vaccine Weekly, September 7th, 1998
The finding, reported in a recent issue of Proceedings of the National Academy of Science, could ultimately have implications for developing re-engineered poliovirus vaccines for HIV, hepatitis B, other viral diseases and cancer, said the senior author of the study, Raul Andino, PhD, an assistant professor of microbiology at UCSF.
Recombinant viruses, engineered with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.